iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
40 hedge funds and large institutions have $168M invested in iKang Healthcare Group, Inc. in 2014 Q2 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$22.2M |
| 2 |
SC
Sculptor Capital
New York
|
+$17.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.8M |
| 4 |
VAM
Visium Asset Management
New York
|
+$12.9M |
| 5 |
AG
Ashmore Group
London,
United Kingdom
|
+$8.48M |
Top Sellers
KANG Hedge Fund Activity: Q2 2014 in Review
40 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2014, worth a combined $168M.
Buyers outnumbered sellers: 40 funds opened new KANG positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $22.2M.
- 40 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $168M of iKang Healthcare Group, Inc. stock for Q2 2014.
- 40 funds opened new iKang Healthcare Group, Inc. positions in Q2 2014 and 0 closed out, a net change of +40 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q2 2014 was JP Morgan Chase, an estimated $22.2M added.
Based on aggregated 13F filings for Q2 2014.